Paul Eggleton

Prof. Paul Eggleton

orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1997 in Nature
Verified
Journal Article
Closed access
STSteffen Thiel
Steffen Thiel
TVThomas Vorup-Jensen
Thomas Vorup-Jensen
Cordula StoverCordula Stover
Cordula Stover
WSWilhelm Schwaeble
Wilhelm Schwaeble
SLSteen B. Laursen
Steen B. Laursen
JJJens C. Jensenius
Jens C. Jensenius

25 November 2009 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
LGLeslie I. Gold
Leslie I. Gold
PEPaul Eggleton
Paul Eggleton
MSMariya T. Sweetwyne
Mariya T. Sweetwyne
LDLauren B. Van Duyn
Lauren B. Van Duyn
MGMatthew R. Greives
Matthew R. Greives
JMJoanne E. Murphy‐Ullrich
Joanne E. Murphy‐Ullrich
Calreticulin (CRT), when localized to the endoplasmic reticulum (ER), has important functions in directing proper conformation of proteins and glycoproteins, as well as in homeostatic control of cytosolic and ER calcium levels. There is also steadily accumulating evidence for diverse roles for CRT localized outside the ER, including data suggesting important roles for CRT localized to the outer cell surface of a variety of cell types, in the cytosol, and in the extracellular matrix (ECM). Furthermore, the addition of exogenous CRT rescues numerous CRT‐driven functions, such as adhesion, migration, phagocytosis, and immunoregulatory functions of CRT‐null cells. Recent studies show that topically applied CRT has diverse and profound biological effects that enhance cutaneous wound healing in animal models. This evidence for extracellular bioactivities of CRT has provided new insights into this classically ER‐resident protein, despite a lack of knowledge of how CRT exits from the ER to the cell surface or how it is released into the extracellular milieu. Nonetheless, it has become clear that CRT is a multicompartmental protein that regulates a wide array of cellular responses important in physiological and pathological processes, such as wound healing, the immune response, fibrosis, and cancer.—Gold, L. I., Eggleton, P., Sweetwyne, M. T., Van Duyn, L. B., Greives, M. R., Naylor, S.‐M., Michalak, M., Murphy‐Ullrich, J. E. Calreticulin: non‐endoplamic reticulum functions in physiology and disease. FASEB J. 24, 665–683 (2010). www.fasebj.org

1 March 2001 in Trends in Cell Biology
Verified
Journal Article
Closed access
SJS Johnson
S Johnson
MMM Michalak
M Michalak
MOM Opas
M Opas
PEPaul Eggleton
Paul Eggleton

1 July 1994 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KHKevan Hartshorn
Kevan Hartshorn
ECE C Crouch
E C Crouch
MWM R White
M R White
PEPaul Eggleton
Paul Eggleton
ATA I Tauber
A I Tauber
KSK Sastry
K Sastry
We tested the hypothesis that pulmonary surfactant-associated lectins--surfactant proteins A and D (SP-A, and -D)--contribute to initial protective mechanisms against influenza A viruses (IAVs). SP-D potently inhibited hemagglutination activity of several strains of IAV as well as causing viral aggregation. SP-D enhanced neutrophil binding of IAV and neutrophil respiratory burst responses to the virus. Neutrophil dysfunction resulting from IAV exposure was diminished when the virus was pre-incubated with SP-D. Each of these effects was mediated by the calcium-dependent carbohydrate-binding property of SP-D. Native SP-D preparations of both human and rat origin, as well as recombinant rat SP-D, had similar activity. SP-A also inhibited IAV hemagglutination activity. We have previously reported that related mammalian serum lectins (mannose-binding lectin [MBL] and conglutinin) have similar effects. SP-D was at least 10-fold more potent at causing hemagglutination inhibition than were SP-A or MBL. SP-D was shown to contribute to potent anti-IAV activity of human bronchoalveolar lavage fluid. These results suggest that SP-D--alone, and in conjunction with SP-A and phagocytic cells--constitutes an important component of the natural immune response to IAV infection within the respiratory tract.

1 November 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SGSilvia Goicoechea
Silvia Goicoechea
AOAnthony Wayne Orr
Anthony Wayne Orr
MPManuel Antonio Pallero
Manuel Antonio Pallero
PEPaul Eggleton
Paul Eggleton
JMJoanne E. Murphy-Ullrich
Joanne E. Murphy-Ullrich
Thrombospondin induces reorganization of the actin cytoskeleton and restructuring of focal adhesions. This activity is localized to amino acids 17–35 in the N-terminal heparin-binding domain of thrombospondin and can be replicated by a peptide (hep I) with this sequence. Thrombospondin/hep I stimulate focal adhesion disassembly through a mechanism involving phosphoinositide 3-kinase activation. However, the receptor for this thrombospondin sequence is unknown. We now report that calreticulin on the cell surface mediates focal adhesion disassembly by thrombospondin/hep I. A 60-kDa protein from endothelial cell detergent extracts has homology and immunoreactivity to calreticulin, binds a hep I affinity column, and neutralizes thrombospondin/hep I-mediated focal adhesion disassembly. Calreticulin on the cell surface was confirmed by biotinylation, confocal microscopy, and by fluorescence-activated cell sorting analyses. Thrombospondin and calreticulin potentially bind through the hep I sequence, since thrombospondin-calreticulin complex formation can be blocked specifically by hep I peptide. Antibodies to calreticulin and preincubation of thrombospondin/hep I with glutathioneS-transferase-calreticulin block thrombospondin/hep I-mediated focal adhesion disassembly and phosphoinositide 3-kinase activation, suggesting that calreticulin is a component of the thrombospondin-induced signaling cascade that regulates cytoskeletal organization. These data identify both a novel receptor for the N terminus of thrombospondin and a distinct role for cell surface calreticulin in cell adhesion.

1 May 1997 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
UWU Wirthmueller
U Wirthmueller
BDB Dewald
B Dewald
MTM Thelen
M Thelen
MSM K Schäfer
M K Schäfer
Cordula StoverCordula Stover
Cordula Stover
WSW J Schwaeble
W J Schwaeble
Properdin is an important regulatory constituent of the complement system. In contrast to most other components of complement, biosynthesis of properdin is restricted to a few cell types only, i.e., monocytes/macrophages and peripheral blood T cells. This report demonstrates the presence of properdin mRNA in peripheral blood granulocytes and shows that properdin is stored in the granules of human neutrophils and secreted upon stimulation with TNF-alpha, C5a, IL-8, or FMLP. Subcellular fractionation using Percoll density gradients and Western blot analyses revealed that the bulk of properdin is contained in the secondary granules. Moreover, flow cytometric analyses indicated that properdin is present on the surface of neutrophils. In contrast to alternative pathway components, components of the classical pathway of complement activation, such as C2 and C4, were not detected. Our findings suggest that neutrophils can actively stabilize and amplify the alternative activation pathway of complement by secretion of properdin as part of the innate defense against microorganisms.